Prognostic difference of surgical treatment of exophytic versus barrel-shaped bulky cervical cancer

Gynecologic Oncology

Volumn 95, Issue 1, 2004, Pages 77-81

  Trimbos, J B ^a   Lambeek, A F ^a   Peters, A A W ^a   Wolterbeek, R ^a   Gaarenstroom, K N ^a   Fleuren, G J ^a   Kenter, G G ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Barrel shaped; Bulky cervical cancer; Exophytic; Stage IB2; Surgical treatment

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DATA ANALYSIS; DATA BASE; FEMALE; HUMAN; HUMAN TISSUE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MEDICAL EXAMINATION; MORBIDITY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RADICAL HYSTERECTOMY; TREATMENT INDICATION; TUMOR LOCALIZATION; UTERINE CERVIX CANCER;

ADULT; AGED; AGED, 80 AND OVER; CELL DIVISION; COHORT STUDIES; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYSTERECTOMY; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; PROSPECTIVE STUDIES; UTERINE CERVICAL NEOPLASMS;

EID: 4644241262     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2004.06.025     Document Type: Article

References (21)

1. Creasman W.T. FIGO news. Modifications in the staging for stage I vulvar and stage I cervical cancer. Int. J. Gynecol. Obstet. 50:1995;215-216
2. Delgado G., Bundy B., Zaino R., Sevin B-U., Creasman W.T., Major F. Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study. Gynecol. Oncol. 38:1990;352-357
3. Eifel P.J., Thoms W.W., Smith T.L., Morris M., Oswald M.J. The relationship between brachytherapy dose and outcome in patients with bulky endocervical tumors treated with radiation alone. Int. J. Radiat. Oncol., Biol. Phys. 28:1994;113-118
4. Landoni F., Maneo A., Colombo A., Placa F., Milani R., Perego P. Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer. Lancet. 350:1997;535-541
5. Hatch K.D. Cervical cancer. Berek J.S., Hacker N.F. Practical gynecologic oncology. 1998;243-283 Williams & Wilkins, Baltimore
6. Bloss J.D., Berman M.L., Mukherherjee J., Manetta A., Emma D., Ramsanghani N.S., et al. Bulky stage IB cervical carcinoma managed by primary radical hysterectomy followed by tailored radiotherapy. Gynecol. Oncol. 47:1992;21-27
7. Burghardt E., Baltzer J., Tulusan A.H., Haas J. Results of surgical treatment of 1028 cervical cancers studied with volumetry. Cancer. 70:1992;648-655
8. Alvarez R.D., Gelder M.S., Gore H., Soong S.J., Partridge E.E. Radical hysterectomy in the treatment of patients with bulky early stage carcinoma of the cervix uteri. Surg. Gynecol. Obstet. 176:1993;539-542
9. Grigsby P.W. Stage IB1 vs. IB2 carcinoma of the cervix: should the new FIGO staging system define therapy? Gynecol. Oncol. 62:1996;135-136
10. Sardi J.E. Neoadjuvant chemotherapy in gynaecologic oncology. Surg. Clin. North Am. 81:2001;965-985
11. Benedetti-Panici P.L., Zullo M.A., Muzii L., Manci N., Bellati F., Plotti F., et al. The role of neoadjuvant chemotherapy followed by radical surgery in the treatment of locally advanced cervical cancer. Eur. J. Gynaecol. Oncol. 24:2003;467-470
12. National Cancer Institute. Concurrent chemoradiation for cervical cancer. Clinical announcement, Washington, DC, February 22, 1999.
13. Thomas G. Improved treatment for cervical cancer-concurrent chemotherapy and radiotherapy. N. Engl. J. Med. 340:1999;1198-1200
14. Goff B.A., Muntz H.G., Paley Pj., Tamimi H.K., Koh W-J., Greer B.E. Impact of surgical staging in women with locally advanced cervical cancer. Gynecol. Oncol. 74:1999;436-442
15. Cosin J.A., Fowler J.M., Chen M.D., Paley P.J., Carson L.F., Twiggs L.B. Pretreatment surgical staging of patients with cervical carcinoma. The case for lymph node debulking. Cancer. 82:1998;2241-2248
16. Hacker N.F., Wain G.V., Nicklin J.L. Resection of bulky positive lymph nodes in patients with cervical carcinoma. Int. J. Gynecol. Oncol. 5:1995;250-256
17. Paley P.J., Goff B.A., Minudri R., Greer B.E., Tamimi H.K., Koh W-J. The prognostic significance of radiation dose and residual tumor in the treatment of barrel-shaped endophytic cervical carcinoma. Gynecol. Oncol. 76:2000;373-379
18. Keys H.M., Bundy B.N., Stehman F.B., Muderspach L.I., Chafe W.E., Suggs C.L. III, et al. Cisplatin, radiation and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma. N. Engl. J. Med. 340:1999;1154-1161
19. Million Women Study Collaborators Breast cancer and hormone-replacement therapy in the Million Women Study. Lancet. 362:2003;419-427
20. Bertelsen K. Sexual dysfunction after treatment of cervical cancer. Dan. Med. Bull. 30S:1983;31-34
21. Peters W.A. III, Liu P.Y., Barrett R.J. II, Stock R.J., Monk B.J., Berek J.S., et al. Concurrent chemotherapy and pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. J. Clin. Oncol. 18:2000;1606-1613